
Please try another search
Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China.
Name | Age | Since | Title |
---|---|---|---|
Wen Chen | - | 2024 | Independent Director |
Shi Hao Dong | 54 | 2006 | Chairman of the Supervisory Board |
Yong Chen | 66 | 2006 | Chairman |
Chunxiang Zhao | 47 | 2021 | Independent Director |
Weilin Duan | 51 | 2015 | Supervisor |
Bing Zhang | 65 | 2021 | Independent Director |
Rengui Hong | 42 | 2021 | MD & Director |
Zidi Chen | 38 | 2024 | Executive Vice President & Non-Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review